SCHEMBL24918625

SCHEMBL24918625

c1ccc(-c2cccc(-c3ccc(N(c4ccc(-c5ccc6oc7ccccc7c6c5)cc4)c4cccc(-c5ccc6ccccc6c5)c4)cc3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 4/20 0.41
▸ PLA2G4A P47712 4/20 0.41
▸ PLA2G10 O15496 1/20 0.41
▸ CASP3 P42574 1/20 0.39
▸ SENP7 Q9BQF6 1/20 0.39
▸ SENP6 Q9GZR1 1/20 0.39
▸ PGR P06401 1/20 0.39
▸ ANO1 Q5XXA6 1/20 0.38
▸ KDM4E B2RXH2 3/20 0.36
▸ MAPT P10636 3/20 0.36
▸ HPGD P15428 3/20 0.36
▸ ALDH1A1 P00352 2/20 0.36
▸ HSD17B1 P14061 1/20 0.36
▸ HSD17B2 P37059 1/20 0.36
▸ MEN1 O00255 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ KMT2A Q03164 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ PRKDC P78527 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23179086 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL23180890 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL23179290 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL23179672 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL24841577 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL23179152 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL23179643 1.00 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL24919176 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL24918730 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7
SCHEMBL23224696 0.99 PLA2G2A (0.41) PLA2G2APLA2G4APLA2G10CASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230024273-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE LEF1, L1CAM, PIEZO1 PLA2G2A 4366/4885PLA2G4A 4679/4885PLA2G10 4244/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback